<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<headerData>
<submissionType>144</submissionType>
<filerInfo>
<filer>
<filerCredentials>
<cik>0001649051</cik>
<ccc>XXXXXXXX</ccc>
</filerCredentials>
</filer>
<liveTestFlag>LIVE</liveTestFlag>
</filerInfo>
</headerData>
<formData>
<issuerInfo>
<issuerCik>0001845257</issuerCik>
<issuerName>LIFESTANCE HEALTH GROUP, INC.</issuerName>
<secFileNumber>001-40478</secFileNumber>
<issuerAddress>
<street1 xmlns="http://www.sec.gov/edgar/common">4800 N. SCOTTSDALE ROAD</street1>
<street2 xmlns="http://www.sec.gov/edgar/common">SUITE 2500</street2>
<city xmlns="http://www.sec.gov/edgar/common">SCOTTSDALE</city>
<stateOrCountry xmlns="http://www.sec.gov/edgar/common">AZ</stateOrCountry>
<zipCode xmlns="http://www.sec.gov/edgar/common">85251</zipCode>
</issuerAddress>
<issuerContactPhone>602-7672100</issuerContactPhone>
<nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Silversmith Capital Partners I-B, L.P.</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
<relationshipsToIssuer>
<relationshipToIssuer>Shareholder</relationshipToIssuer>
</relationshipsToIssuer>
</issuerInfo>
<securitiesInformation>
<securitiesClassTitle>Common Stock</securitiesClassTitle>
<brokerOrMarketmakerDetails>
<name>Morgan Stanley &amp; Co. LLC</name>
<address>
<street1 xmlns="http://www.sec.gov/edgar/common">1585 Broadway</street1>
<city xmlns="http://www.sec.gov/edgar/common">New York</city>
<stateOrCountry xmlns="http://www.sec.gov/edgar/common">NY</stateOrCountry>
<zipCode xmlns="http://www.sec.gov/edgar/common">10036</zipCode>
</address>
</brokerOrMarketmakerDetails>
<noOfUnitsSold>894098</noOfUnitsSold>
<aggregateMarketValue>4837070.18</aggregateMarketValue>
<noOfUnitsOutstanding>388936394</noOfUnitsOutstanding>
<approxSaleDate>08/18/2025</approxSaleDate>
<securitiesExchangeName>NASDAQ</securitiesExchangeName>
</securitiesInformation>
<securitiesToBeSold>
<securitiesClassTitle>Common Stock</securitiesClassTitle>
<acquiredDate>06/10/2021</acquiredDate>
<natureOfAcquisitionTransaction>Pre-IPO Transactions</natureOfAcquisitionTransaction>
<nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
<isGiftTransaction>N</isGiftTransaction>
<amountOfSecuritiesAcquired>5130460</amountOfSecuritiesAcquired>
<paymentDate>06/10/2021</paymentDate>
<natureOfPayment>Equity interests in the Issuer were purchased pre-IPO</natureOfPayment>
</securitiesToBeSold>
<nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
<remarks>Sales by Seller should be aggregated with the sale of common stock by Summit Partners Growth Equity Fund IX-A, L.P., Summit Partners Growth Equity Fund IX-B, L.P., Summit Investors GE IX-VC IV, LLC, Summit Investors GE IX-VC IV (UK), L.P., Summit Partners Entrepreneur Advisors II, L.P., Silversmith Capital Partners I-A, L.P., and Silversmith Capital Partners I-C, L.P. (together with Seller, the "Selling Shareholders"). The Selling Shareholders have filed separate Forms 144 for aggregate sales of 12,000,000 shares of common stock during the past three months.</remarks>
<noticeSignature>
<noticeDate>08/18/2025</noticeDate>
<signature>/s/ Jeff Crisan</signature>
</noticeSignature>
</formData>
</edgarSubmission>
